Our News on Newswise

The University of Kansas Cancer Center Among the First to Offer CAR T-cell Therapy to Treat Multiple Myeloma

The University of Kansas Cancer Center is the first and only site in the region to offer CAR T-cell therapy to treat multiple myeloma, a type of blood cancer that affects about 30,000 people each year.
29-Mar-2021 2:00 PM EDT Add to Favorites

The University of Kansas Cancer Center Joins Leading Cancer Organizations to Warn Cancer Doesn’t Stop for COVID-19 and Neither Should You

The University of Kansas Cancer Center is part of a nationwide effort to resume appropriate cancer screening and treatment to prevent excess deaths.
28-Jan-2021 9:15 AM EST Add to Favorites

Cancer center is a contributor to 49 research studies at the 62nd American Society of Hematology Annual Meeting

Researchers from The University of Kansas Cancer Center are involved in the presentation of nearly 50 research studies at the 62nd American Society of Hematology (ASH) Annual Meeting.
4-Dec-2020 1:25 PM EST Add to Favorites

Newswise: KasiAnupOncology2015NEW.JPG

Researchers discover men fighting both cancer and COVID-19 at higher risk than women

Men with cancer and COVID-19 may be at significantly higher risk for severe symptoms and even death as compared to females fighting both, a University of Kansas Cancer Center research team has found.
23-Nov-2020 12:50 PM EST Add to Favorites

Newswise: NikkiNollen.jpg

Are E-cigarettes Safer Than Cigarettes? Study Sheds Light on the Issue

Scientists and medical professionals have long debated whether pod e-cigarettes are a safer alternative to traditional cigarettes. A new study provides some insight.
18-Nov-2020 3:25 PM EST Add to Favorites

One year out, cancer center countdown to applying for NCI comprehensive status kicks into high gear

In one year, The University of Kansas Cancer Center will submit its application to renew its prestigious National Cancer Institute (NCI) designation in the hopes of attaining “comprehensive” status, the NCI’s highest ranking.
1-Oct-2020 11:15 AM EDT Add to Favorites

Cancer center exceeds NCORP clinical trial accrual goals

The University of Kansas Cancer Center’s status as a community site of the National Cancer Institute’s Community Oncology Research Program has been renewed after exceeding clinical trial accrual goals by more than 22% in its first year.
24-Sep-2020 12:25 PM EDT Add to Favorites

Newswise: GanGregoryRadiationOncology.jpg

Researchers pivot from studying cancer and cystic fibrosis to launch trial of drug to fight COVID-19

The University of Kansas Medical Center announced today a trial exploring a drug intended to fight the cytokine storm common in COVID-19.
14-Aug-2020 9:00 AM EDT Add to Favorites

See All News

Our Experts on Newswise


Triple-negative breast cancer expert Dr. Priyanka Sharma discusses latest research and clinical trial efforts.
18-Jul-2018 1:35 PM EDT

Newswise: KlempJennifer2008.jpg

Getting Survivorship Care Planning Off the Page and Into Practice

Jennifer Klemp, PhD, MPH, director of cancer survivorship and an associate professor at The University of Kansas Cancer Center, is interviewed by Oncology Nursing News. In this interview, Klemp offers insights on some of the critical issues that...
31-Oct-2016 9:30 AM EDT

Newswise: JChien_Lawrence.jpg

Rewriting the Book on Chemo-Resistant Cancers with a DNA Library

KU Cancer Center researcher is finding out why ovarian cancer is resistant to certain types of chemo to eventually identify a different drug target.
30-Jun-2015 5:05 PM EDT

See All Experts

Our YouTube Videos


The University of Kansas Cancer Center is a world-class, community-based, NCI-designated cancer research and care partnership spanning two states and involving collaboration among researchers, physicians and cancer support professionals. Together, we are working toward a world without cancer. The University of Kansas Cancer Center is transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our nationally accredited patient care program. Our partnership includes cancer research and health care professionals associated with the University of Kansas Medical Center and The University of Kansas Hospital in Kansas City, The University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita, The Stowers Institute for Medical Research and the members of the Midwest Cancer Alliance. Our research programs include Cancer Biology, Cancer Prevention, Cancer Control and Population Health, and Drug Discovery, Delivery and Experimental Therapeutics. Shared resources include Biospecimen, Biostatistics and Informatics, Clinical Research Office and Lead Development and Optimization.

Disease-specific working groups, including both clinicians and basic research investigators, promote collaborative opportunities and the exchange of research ideas. The disease working groups define clinical research priorities respective to their disease specialty with an emphasis on Investigator Initiated Trials (IITs). The cancer center’s current disease working groups include lung, hematology/bone marrow transplant, gastrointestinal, genitor-urinary, head and neck, breast and brain.

Breaking new ground in cancer research requires state-of-the-art facilities. A 82,400-square-foot University of Kansas Clinical Research Center, which opened in January 2012, houses the Phase I clinical trials program. A recently remodeled, 170,000-square-foot Wahl/Hixon research complex, known as The Kansas Masonic Cancer Research Institute, will house 37 cancer-focused researchers. Building a world-class cancer center that is at the forefront of discovery, development and implementation is just the beginning. The legacy of The University of Kansas Cancer Center endures when discoveries made here benefit cancer patients everywhere.



Kay Hawes
Assoc. Dir of News & Media Relations
Health Care



Pauline Horton
Communications Specialist



Natalie Lutz
Executive Director, Marketing & University Relatio



Marilyn Nielsen
Executive Assistant


Donna Peck
Assistant Communications Director



Christine Wilson
Director of Public Relations